Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESHerculite Products, Inc. Promotes Two Employees to New Roles

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty is being promoted to the newly created position of Chief Strategy Officer Marco Angelone is being promoted to the role of Chief Financial Officer

MARKET REPORTS

Global $45 Billion Endoscopy Market Insights & Forecasts to 2025

The global endoscopy market is predicted to reach US$45.28 billion in 2025, growing, at a CAGR of 7.50%, for the duration spanning 2021-2025.

Global Remote Monitoring Devices Market Research Report (2021 to 2026)

Global Remote Monitoring Devices Market size was estimated at USD 1,035.35 million in 2020, is expected to reach USD 1,170.22 million in 2021.

Research Efforts Fuel the Future of Global Obstructive Lung Disease Management Markets – ResearchAndMarkets.com

The "Global Obstructive Lung Disease Management Research Report" report has been added.

Global Electrophysiology Market (2021 to 2026) – Growth, Trends , COVID-19 Impact and Forecasts – ResearchAndMarkets.com

The Electrophysiology Market is expected to register a CAGR of 8.5% during the forecast period.

Emigsville, Pa: Herculite Products Inc., a leading innovator and manufacturer of high-performance and custom fabrics are pleased to announce that Paul Flaherty and Marco Angelone have received leadership promotions.

Paul Flaherty is being promoted to the newly created position of Chief Strategy Officer. In this new role, Paul will be responsible for the development and implementation of the company’s long-range strategic initiatives.

Paul Flaherty is a CPA who earned his bachelor’s degree from Duquesne University and his master’s degree from Mount St Mary’s University. He has been with Herculite for 10 years serving as the Chief Financial Officer. Prior to coming to Herculite, he served as the CFO of several local companies.

Marco Angelone is being promoted to the role of Chief Financial Officer to fill Paul’s vacancy. Marco is a CPA who earned his bachelor’s degree from Kutztown University. He has been with Herculite for two years in his role as Controller. Prior to coming to Herculite, he spent six years at RKL as the Audit Manager.

Both positions will report to President and CEO, Peter McKernan. Marco and Paul will continue to provide leadership and strategic vision to Herculite as we continue to invest and expand our operations and capabilities to better serve our customer-partners.

spot_img

DON'T MISS

Children Achieve Time in Range Mirroring Well-controlled Adults for the 1st Time in Real-world Study of the MiniMed™ 780G System

"These results are extremely encouraging. Glycemic control has been much harder to achieve in children due to unpredictable factors common in this age group, including physical growth and development, hormonal changes and active lifestyles.

Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

The publication documents two critically ill COVID-19 patients receiving a combined total of nine, six-hour Hemopurifier® treatment sessions.

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

For people with lymphedema, movement is important from both a clinical perspective and a quality-of-life perspective. These data illustrate the Dayspring treatment’s ability to provide that essential movement while still delivering the clinical outcomes we need from compression therapy.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy